| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |